Vulvar Cancer

Get Schooled on Vulvar Cancer

April 10th 2020, 10:00pm

Article

A patient turned advocate underscores the importance of education, especially for those facing a rare cancer.

New Issue Alert: CURE Women's Cancers

April 4th 2019, 7:00pm

Article

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

January 25th 2019, 10:56pm

Article

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

FDA Approves Age Expansion of HPV Vaccine

October 6th 2018, 1:05am

Article

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

June 13th 2018, 4:55pm

Article

The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.

HPV Status Linked to Overall and Disease-Free Survival in Vulvar Cancer

March 21st 2018, 10:26pm

Article

Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.

Despite Benefits, HPV Vaccination Rates Remain Too Low

May 18th 2017, 6:16pm

Article

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

NCCN Introduces Updated Vulvar Cancer Guideline

April 27th 2017, 5:26pm

Article

Treatment changes for the rare illness include less invasive surgery.

HPV Vaccination in Boys Found Cost-Effective in Preventing Oropharyngeal Cancer

April 17th 2015, 9:24pm

Article

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

Study Highlights Geographical Differences in Cervical Cancer Incidence

February 20th 2015, 7:57pm

Article

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.